Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

669
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
669
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

72.5K
Overview
72.5K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

5.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
5.6K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

3.2K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive Cavity-Enabled Crystalline Chirality in Nanocarbon Cages.

Angewandte Chemie (International ed. in English)·2026
Same author

Facile Preparation of a Poly[2]Catenane Network Using Self-Assembled [2]Catenane Unit.

Angewandte Chemie (International ed. in English)·2026
Same author

Fused Metallo-Carbaporphyrin-Embedded Graphene Nanoribbon Segments.

Journal of the American Chemical Society·2026
Same author

Recognition-Based Chiral Amplification through Adaptive Locking.

Journal of the American Chemical Society·2026
Same author

Nanobody-Conjugated Theranostic Prodrug Targeting α<sub>v</sub>β<sub>3</sub> Integrin Enables Precision Cancer Therapy With Real-Time Imaging.

Advanced healthcare materials·2026
Same author

A next-generation multimetal complex induces immunogenic cell death with distinct transcriptomic signatures.

Chemical communications (Cambridge, England)·2026

Related Experiment Video

Updated: Sep 11, 2025

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
07:17

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex

Published on: August 2, 2021

2.6K

Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death.

Tomer Babu1, Matthew S Levine1, Sourav Acharya2

  • 1Department of Chemistry, The University of Texas at Austin, 105 East 24th Street, Austin, Texas, 78712-1224, USA.

Angewandte Chemie (International Ed. in English)
|August 12, 2025
PubMed
Summary

Researchers developed a novel tri-metallic prodrug that effectively triggers immunogenic cell death (ICD) in colorectal cancer models. This single compound enhances anti-tumor immunity and reduces side effects, offering a promising new chemo-immunotherapy approach.

Keywords:
Gold(I) N‐heterocyclic carbenesImmunogenic cell deathMetals in medicinePlatinum(IV) prodrugsRuthenium(II) 2‐pyridinecarbothioamides

More Related Videos

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

9.9K

Related Experiment Videos

Last Updated: Sep 11, 2025

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
07:17

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex

Published on: August 2, 2021

2.6K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

9.9K

Area of Science:

  • Metal-based therapeutics
  • Cancer immunotherapy
  • Regulated cell death

Background:

  • Immunogenic cell death (ICD) stimulates adaptive immunity via damage-associated molecular patterns (DAMPs).
  • Metal complexes show potential as ICD inducers, but multi-metal conjugates are underexplored.
  • Existing ICD inducers often lack multimodal therapeutic integration.

Purpose of the Study:

  • To design, synthesize, and evaluate a novel tri-metallic prodrug (AuI-PtIV-RuII) for enhanced ICD induction.
  • To investigate the prodrug's mechanism of action, including DAMP release and immune cell activation.
  • To assess the in vivo efficacy and safety of the tri-metallic prodrug in a colorectal cancer model.

Main Methods:

  • Synthesis of a single scaffold tri-metallic prodrug (AuI-PtIV-RuII) codelivering oxaliplatin, RuII arene, and Au(I) species.
  • In vitro assessment of prodrug-induced thioredoxin reductase inhibition, reactive oxygen species (ROS) production, and DAMP release.
  • In vivo evaluation in a colorectal cancer mouse model, including tumor growth suppression, metal accumulation analysis, and immune memory assessment via tumor challenge.
  • Peripheral white blood cell (WBC) profiling to analyze innate and adaptive immune activation.

Main Results:

  • The tri-metallic prodrug effectively released cytotoxic species upon reduction, enhancing TrxR1&2 inhibition and ROS production.
  • In vitro studies showed significant DAMP release, indicating ICD induction.
  • In vivo studies demonstrated superior tumor growth suppression compared to a mixture of individual agents.
  • Reduced off-target metal accumulation and enhanced immune memory were observed in the tri-metallic prodrug group.
  • WBC profiling confirmed activation of both innate and adaptive immune compartments.

Conclusions:

  • The tri-metallic prodrug represents an integrated chemo-immunotherapeutic strategy, unifying multiple ICD triggers.
  • This single-scaffold approach offers a promising platform for developing multimodal metal-based anticancer therapies.
  • The study highlights the potential of combining different metal-based cytotoxic agents within a single prodrug for enhanced anti-tumor immunity.